Events

Recall of AMPLILINK SOFTWARE V 3.2

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ROCHE DIAGNOSTICS.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    21864
  • Event Risk Class
    II
  • Event Initiated Date
    2010-06-23
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Out-of-range control failures flagged as failed did not invalidate patient samples in the batch for the customers using the amplilink sw 3.1.X & 3.2.X in combination with cobas ampliprep / cobas taqman.

Device

AMPLILINK SOFTWARE V 3.2
  • Model / Serial
    Model Catalog: 04862392001 (Lot serial: ); Model Catalog: 04855094001 (Lot serial: ); Model Catalog: 05201357001 (Lot serial: ); Model Catalog: 04807197001 (Lot serial: ); Model Catalog: 05093236001 (Lot serial: ); Model Catalog: 05666678001 (Lot serial: )
  • Product Description
    Amplilink Software V3.2
  • Manufacturer
    ROCHE DIAGNOSTICS

Manufacturer

ROCHE DIAGNOSTICS
  • Manufacturer Address
    LAVAL
  • Manufacturer Parent Company (2017)
    Roche Holding AG
  • Source
    HC